Search results
Results from the WOW.Com Content Network
The economic effects of intellectual property reform in India is a complex subject area, and would require a separate detailed article. A beginning may be made by referring to Sunil Kanwar and Stefan Sperlich (2020), [18] who study the effect of intellectual property reform on technological advancement and productivity increases in manufacturing industry in the emerging market context of India.
Novartis v. Union of India & Others is a landmark decision by a two-judge bench of the Indian Supreme Court on the issue of whether Novartis could patent Gleevec in India, and was the culmination of a seven-year-long litigation fought by Novartis. The Supreme Court upheld the Indian patent office's rejection of the patent application.
The Office of the Controller General of Patents, Designs and Trade Marks (CGPDTM) generally known as the Indian Patent Office, is an agency under the Department for Promotion of Industry and Internal Trade which administers the Indian law of Patents, Designs and Trade Marks. [1] [2]
Toe stirrup – The earliest known manifestation of the stirrup, which was a toe loop that held the big toe was used in India in as early as 500 BCE [110] or perhaps by 200 BCE according to other sources. [111] [112] This ancient stirrup consisted of a looped rope for the big toe which was at the bottom of a saddle made of fibre or leather. [112]
Ananda Mohan Chakrabarty (Bengali: আনন্দমোহন চক্রবর্তী Ānandamōhan Cakrabartī), PhD (4 April 1938 – 10 July 2020) was an Indian American microbiologist, scientist, and researcher, most notable for his work in directed evolution and his role in developing a genetically engineered organism using plasmid transfer while working at GE, the patent for which ...
Hridayeshwar Singh Bhati (3 September 2002 – 15 June 2021) was an Indian student who invented a six-player variant of chess at the age of 9 with assistance from his father. [1] [3] He earned a patent for his invention in 2012, making him the youngest patent-holder in India at that time.
The bipartisan PREVAIL Act and RESTORE Patent Rights Act would make critical reforms to curb the abuse of the U.S. patent system by Big Tech.
Indian Drugs and Pharmaceuticals Limited (IDPL) was a public sector pharmaceutical, bulk drug manufacturing and drug discovery company owned by the Indian government, headquartered in New Delhi, and located in Hyderabad, Gurgaon and Rishikesh. [1]